drugset / Trial / NCT01596530

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

NCT01596530

Phase 1 Terminated 3 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

To compare the activity of AZD8931 against placebo on the cell markers in cancer tumours

Timeline

Start
2012-06
Primary completion
2013-03
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator SAPITINIB Small molecule

Indications